John Kim
Pediatric Radiology Seattle, WA Medical Doctor
NPI 1376527382 CMS profile 106952
1959 Ne Pacific St, Seattle, WA 98195
General payments
$377
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, John Kim of Seattle, WA is reported in the CMS Open Payments database as having received $377 across 11 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 67th percentile of Pediatric Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $188 | 6 | |
| 2024 | General | $120 | 1 | |
| 2023 | General | $57 | 3 | |
| 2019 | General | $12 | 1 |
Beside peers
- John Kim
- Pediatric Radiology median
- Middle half of Pediatric Radiology
- National median
In program year 2025, general payments to John Kim were reported at $188. Among 152 Pediatric Radiology profiles paid that year, the median was $141 and the middle half received between $39 and $408.
Show as a table
| Year | John Kim | Pediatric Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $12 | $78 | $28–$317 | $163 |
| 2020 | $0 | $44 | $17–$200 | $114 |
| 2021 | $0 | $71 | $16–$226 | $132 |
| 2022 | $0 | $80 | $20–$278 | $149 |
| 2023 | $57 | $68 | $25–$252 | $160 |
| 2024 | $120 | $105 | $31–$352 | $164 |
| 2025 | $188 | $141 | $39–$408 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 202 billing codesPaid by Medicare
$158,710
Medicare patients
4,360
Services billed
6,848
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 62% | |
| Ischemic heart disease | 41% | |
| Diabetes | 39% | |
| Chronic kidney disease | 39% | |
| Depression | 39% | |
| Heart failure | 33% | |
| Atrial fibrillation | 32% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
11 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Radiology in Washington
Alex Chau
Pediatric Radiology · Seattle, WA
Robert Raines-Hepple
Pediatric Radiology · Seattle, WA
Arta-Luana Stanescu
Pediatric Radiology · Seattle, WA
John MacKenzie
Pediatric Radiology · Lynnwood, WA
Mahesh Thapa
Pediatric Radiology · Seattle, WA
Patricia Acharya
Pediatric Radiology · Seattle, WA
Related records
Pediatric Radiology in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Radiology
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.